⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Samuel ShaverMD

Family Practice · Anderson, IN 46011

NPI: 1093065377

Share:

24

🟡 Moderate

Risk Flags

High long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

10,022

Total Claims

$1.5M

Drug Cost

681

Beneficiaries

$2,271

Cost/Patient

Risk Score Breakdown 24/100

Low (0)Moderate (15)Elevated (30)High (50+)
Long-acting opioid rate+8
Opioid + benzodiazepine combo+8
Elderly antipsychotic prescribing+5

Score components are additive. Read full methodology

Peer Comparison vs. 106,889 Family Practice providers

-32%

Opioid rate vs peers

1.7% vs 2.6% avg

+113%

Cost per patient vs peers

$2,271 vs $1,068 avg

+81%

Brand preference vs peers

16.3% vs 9.0% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.7%

Opioid Rate

175

Opioid Claims

$23K

Opioid Cost

27.4%

Long-Acting Rate

Brand vs Generic

84% generic

Brand: 1,618 claims · $1.3M

Generic: 8,313 claims · $221K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Dapagliflozin Propanediol194$192K
Empagliflozin112$140K
Sitagliptin Phos/Metformin Hcl81$88K
Semaglutide53$83K
Dulaglutide42$68K
Tirzepatide44$56K
Apixaban39$51K
Dapaglifloz Propaned/Metformin39$46K
Semaglutide40$42K
Sitagliptin Phosphate29$42K
Insulin Glargine,hum.Rec.Anlog34$34K
Empagliflozin/Metformin Hcl22$29K
Fluticasone/Umeclidin/Vilanter18$28K
Rivaroxaban14$21K
Finerenone15$20K

Prescribing Profile

147

Unique Drugs

$446K

IRA Negotiated Drugs

$249K

GLP-1 Drugs

24.0

Anomaly Score

Patient Profile

71

Avg Age

47%

Female

1.29

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data